Akanda Corp.

US$0.84As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AKANHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (94.28%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 14.25
PE TTM —
TSR TTM (97.68%)
Mkt cap US$2.217M
ROIC (179.40%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.991
17.99%
(35.03%)
Hold 5|1|4|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
7.23%
18.26%
2.17%
3.75%
Revenue$M
0.168
0.164
0.163
0.160
1.60%
(3.45%)
(4.19%)
(5.67%)
Peers (US$2.217M)
Cap (US$)
PE
2.268M
0.277x
Capital
TTM
5Y
10Y
Leveragex
1.310
0.024
0.026
EBIT/Intx
2.032
0.505
0.484
Own earn%
54.25
(5.08)
(7.81)
Sh yield%
47.25
38.63
38.70
Owners
Insiders/Inst%
12.09
54.72
Short interest%
5.71
SBC / revenue%
1.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
11–20
$1 testx
—
Incr. ROIC%
5